News
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...
21hon MSN
Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...
The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...
In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...
Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.
Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...
India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...
India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly ...
Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...
The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results